The Recall Desk

FDA (Drugs) recall action 80128

Shoreside Enterprises Inc. recalled 2 products on 2018-06-06

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2018-06-06
Critical
2
Units

Why these products were recalled

Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.

The agency’s own wording, quoted from the enforcement report.

1–2 of 2

  • CriticalFDA (Drugs)··2018-06-06

    FDA Recalls 7K Capsules Containing Undeclared Sildenafil and Tadalafil

    The FDA is recalling 7K capsules distributed by SX Power Co. because they contain undeclared sildenafil and tadalafil, making them unapproved drugs with unestablished safety and efficacy.

    Product
    7K capsules packaged in single packs sold in 24-count boxes, Distributed by SX Power Co. San Diego, CA 92108, UPC 601577513148
    Category
    Distribution
    0 states
  • CriticalFDA (Drugs)··2018-06-06

    Poseidon Platinum 4500 Recalled for Undeclared Sildenafil and Tadalafil

    Shoreside Enterprises Inc. is recalling Poseidon Xtreme PLATINUM 4500 because FDA analysis found undeclared sildenafil and tadalafil, making it an unapproved drug.

    Product
    POSEIDON Xtreme PLATINUM 4500,1000mg, packaged in single packs sold in 24-count boxes, Distributed by: Poseidon Distribution Atlanta, GA, UPC 638632428857
    Category
    Distribution
    0 states